The 12th Annual 3D Tissue Models Summit 2027 explores advancements in 3D tissue models, focusing on reproducibility, scalability, toxicity prediction, and their applications in drug discovery and disease research.
Key Topics
Standardizing Protocols to Enable Effective Reproducibility Across Different Models
Spotlighting Lessons Learned from Augmenting 3D Tissue Models Across Multiple Disease Areas
Enhancing Model Adoption Internally & Externally
Crafting the Right Balance Between Scalability, Model Complexity, & Throughput
Applications of 3D Tissue Models to Support ADME & DMPK Studies
Uncovering Optimized Strategies to Boost Toxicity Predictability Power Using Model Data
Exploring the Future of Modeling & Spotlighting Newer Tools to Empower Drug Discovery
